Published in Hypertension on August 01, 1998
Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int (2011) 2.15
Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension. Hypertension (2008) 2.09
NOX and inflammation in the vascular adventitia. Free Radic Biol Med (2009) 1.37
NADPH oxidases in heart failure: poachers or gamekeepers? Antioxid Redox Signal (2012) 1.27
Nox4 oxidase overexpression specifically decreases endogenous Nox4 mRNA and inhibits angiotensin II-induced adventitial myofibroblast migration. Hypertension (2008) 1.26
Targeting NADPH oxidases in vascular pharmacology. Vascul Pharmacol (2012) 1.20
NADPH oxidases in vascular pathology. Antioxid Redox Signal (2013) 1.17
Role of oxidative stress and nitric oxide in atherothrombosis. Front Biosci (2008) 1.10
Redox control of vascular smooth muscle migration. Antioxid Redox Signal (2010) 1.06
Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteries. Circulation (2010) 1.00
NADPH oxidase expression and production of superoxide by human corneal stromal cells. Mol Vis (2009) 0.95
NADPH oxidase as a therapeutic target for oxalate induced injury in kidneys. Oxid Med Cell Longev (2013) 0.95
NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system? J Clin Pathol (2002) 0.90
Differential role of angiotensin II receptor subtypes on endothelial superoxide formation. Br J Pharmacol (2000) 0.89
The adventitia: Essential role in pulmonary vascular remodeling. Compr Physiol (2011) 0.85
Reduced angiotensin II levels cause generalized vascular dysfunction via oxidant stress in hamster cheek pouch arterioles. Microvasc Res (2013) 0.83
Activated intrarenal reactive oxygen species and renin angiotensin system in IgA nephropathy. Minerva Urol Nefrol (2009) 0.82
Adventitial gene transfer of catalase attenuates angiotensin II-induced vascular remodeling. Mol Med Rep (2014) 0.78
Expression and distribution of NADPH oxidase isoforms in human myometrium--role in angiotensin II-induced hypertrophy. Biol Reprod (2009) 0.78
NADPH oxidase p47phox siRNA attenuates adventitial fibroblasts proliferation and migration in apoE(-/-) mouse. J Transl Med (2015) 0.77
Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis - a randomized cross-over study. BMC Nephrol (2015) 0.76
Action mechanism and cardiovascular effect of anthocyanins: a systematic review of animal and human studies. J Transl Med (2016) 0.75
Tea polyphenols alleviate high fat and high glucose-induced endothelial hyperpermeability by attenuating ROS production via NADPH oxidase pathway. BMC Res Notes (2014) 0.75
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med (1996) 12.77
Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) (2000) 7.17
Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. Circulation (1996) 3.98
Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med (2001) 3.44
Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation (1998) 2.91
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis : role of a pertussis toxin-sensitive G protein. Circulation (1999) 2.50
Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res (2000) 2.36
Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol (2001) 2.28
Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol (1988) 2.25
Single nucleotide polymorphic discrimination by an electronic dot blot assay on semiconductor microchips. Nat Biotechnol (1999) 2.17
Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. N Engl J Med (1980) 2.15
Functional significance of presynaptic alpha-adrenergic receptors in failing and nonfailing human left ventricle. Circulation (1995) 2.00
Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation (1997) 2.00
An areawide survey of treated end-stage renal disease. Am J Public Health (1978) 1.98
Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes. Circ Res (2001) 1.97
Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. N Engl J Med (1981) 1.97
Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest (1998) 1.96
Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin. J Clin Endocrinol Metab (2000) 1.90
Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation (1981) 1.90
Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. Clin Infect Dis (2001) 1.86
Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. J Am Coll Cardiol (1983) 1.81
Modulation of cardiac autonomic activity during and immediately after exercise. Am J Physiol (1989) 1.81
Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci U S A (1997) 1.80
Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res (1995) 1.75
PCR and single-strand conformational polymorphism for recognition of medically important opportunistic fungi. J Clin Microbiol (1995) 1.73
Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction. Circ Res (2001) 1.70
Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure. Circulation (2000) 1.69
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2. N Engl J Med (1986) 1.69
Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation (2000) 1.63
Rapid extraction of genomic DNA from medically important yeasts and filamentous fungi by high-speed cell disruption. J Clin Microbiol (1998) 1.60
Gene targeting of X chromosome-linked chronic granulomatous disease locus in a human myeloid leukemia cell line and rescue by expression of recombinant gp91phox. Proc Natl Acad Sci U S A (1993) 1.60
Vascular endothelial growth factor gene haplotypes in Kawasaki disease. Arthritis Rheum (2006) 1.59
Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest (1998) 1.58
Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res (2001) 1.56
Long-term sequential changes in exercise capacity and chronotropic responsiveness after cardiac transplantation. Circulation (1997) 1.54
Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol (2001) 1.52
Effects of myocardial alpha 1-adrenergic receptor stimulation and blockade on contractility in humans. Circulation (1991) 1.48
Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance. Circulation (1997) 1.45
Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation (2000) 1.43
Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation (1990) 1.42
Impaired cell shortening and relengthening with increased pacing frequency are intrinsic to the senescent mouse cardiomyocyte. J Mol Cell Cardiol (2000) 1.40
Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes. J Clin Invest (1994) 1.36
MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol (2001) 1.35
GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis (2010) 1.35
The phosphorylation targets of p47phox, a subunit of the respiratory burst oxidase. Functions of the individual target serines as evaluated by site-directed mutagenesis. J Clin Invest (1995) 1.34
Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript. Hum Genet (2011) 1.32
Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India. Genes Immun (2001) 1.32
Sequence analysis of the mannose-binding lectin (MBL2) gene reveals a high degree of heterozygosity with evidence of selection. Genes Immun (2004) 1.32
Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res (1999) 1.31
Phorbol ester increases the dihydropyridine-sensitive calcium conductance in a vascular smooth muscle cell line. Circ Res (1988) 1.31
Long-term therapy of heart failure with prazosin: a randomized double blind trial. Am J Cardiol (1980) 1.30
A p47-phox pseudogene carries the most common mutation causing p47-phox- deficient chronic granulomatous disease. J Clin Invest (1997) 1.30
Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer (2007) 1.27
Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol (2000) 1.26
Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest (1995) 1.25
Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation (2001) 1.25
Genetic reassortment of mammalian reoviruses in mice. J Virol (1985) 1.24
Genome-wide meta-analyses of smoking behaviors in African Americans. Transl Psychiatry (2012) 1.23
p38 mitogen-activated protein kinase pathway protects adult rat ventricular myocytes against beta -adrenergic receptor-stimulated apoptosis. Evidence for Gi-dependent activation. J Biol Chem (2000) 1.22
Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs. J Clin Invest (1995) 1.22
Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol (2001) 1.22
Invasive fungal infections in children: recent advances in diagnosis and treatment. Adv Pediatr Infect Dis (1996) 1.21
Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone. Circulation (1984) 1.20
Adrenergic regulation of myocardial apoptosis. Cardiovasc Res (2000) 1.18
Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis (2006) 1.17
SNPs in cancer research and treatment. Br J Cancer (2004) 1.16
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1. N Engl J Med (1986) 1.14
Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis (2007) 1.12
Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsiveness. Circulation (1998) 1.11
Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma. Leukemia (2010) 1.11
Human rotaviruses and genome RNA. J Infect Dis (1983) 1.09
Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation (1995) 1.09
Apoptosis in the heart. N Engl J Med (1996) 1.09
The reovirus M1 gene determines the relative capacity of growth of reovirus in cultured bovine aortic endothelial cells. J Clin Invest (1993) 1.09
New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress. Lancet (1998) 1.08
Regulation of the postsynaptic alpha-adrenergic receptor in rat mesenteric artery. Effects of chemical sympathectomy and epinephrine treatment. Circ Res (1981) 1.07
Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. Leukemia (2008) 1.07
Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis. Antimicrob Agents Chemother (1997) 1.07
Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphisms. Carcinogenesis (2008) 1.06
Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation (1995) 1.05
An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood (2000) 1.05
Myocardial osteopontin expression coincides with the development of heart failure. Hypertension (1999) 1.04
Tetracycline-induced pleural symphysis for recurrent hydrothorax complicating cirrhosis. A new approach to treatment. Gastroenterology (1977) 1.02
Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group. J Card Fail (1997) 1.02
Nonlinear relationship between alpha 1-adrenergic receptor occupancy and norepinephrine-stimulated calcium flux in cultured vascular smooth muscle cells. Mol Pharmacol (1985) 1.02
Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure. Am J Med (1981) 1.02
Regulation of angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells: role of p42/44 mitogen-activated protein kinase and reactive oxygen species. J Cell Physiol (2001) 1.02
Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3). J Clin Endocrinol Metab (2010) 1.00
Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease. Blood (2000) 1.00
Analysis of nucleotide diversity of NAT2 coding region reveals homogeneity across Native American populations and high intra-population diversity. Pharmacogenomics J (2006) 1.00
Increased vascular catecholamine sensitivity and alpha-adrenergic receptor affinity in female and estrogen-treated male rats. Circ Res (1982) 0.99
Pharmacists' concerns and suggestions related to the sale of tobacco and alcohol in pharmacies. J Community Health (1998) 0.99
Beta-adrenergic receptor number and adenylate cyclase function in denervated transplanted and cardiomyopathic human hearts. Circulation (1989) 0.99
Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria. J Infect Dis (1999) 0.98
Variant genotypes of FcgammaRIIIA influence the development of Kaposi's sarcoma in HIV-infected men. Blood (2000) 0.98